Elevated Perspectives: Maturing Your AWS Environment for Growth
Strategies to Propel Your Scientific Evolution
In this session, RCH experts Michael Riener, CEO, and Phil Eschallier, CTO, alongside Steve Litster, Senior Manager, Compute Specialists for Healthcare & Life Sciences, AWS, will demystify the complexity when evolving your AWS platform as your scientific needs become more complex. Gain practical insights into the critical Cloud-based resources, technologies, and workflows essential for navigating the path from early discovery, through clinical development, and beyond.
To view all events in this series, click here.
Meet The Speakers
With over 30 years of experience as a managerial and technical computing professional, Phil currently leads RHC’s Managed Services capabilities and is responsible for all elements of the customer experience, including requirements and resources management and services definitions and delivery. His professional background includes solutions architecting, scientific and high-performance computing design and support, life sciences applications management, and software engineering from management and technical perspectives.
After obtaining his PhD in Chemical Crystallography in 1992, Steve continued his research career at the University of Calgary in the area of protein crystallography. During this time, he was exposed to his first supercomputer and realized the impact HPC could have on scientific discovery. In 1998 he was awarded an HHMI Medical Fellowship working under the supervision of Professors Don Wiley and Steve Harrison in the area of macromolecular and computational crystallography at Harvard University. In 2004 he joined the Novartis Institutes for Biomedical Research as the Global lead for Scientific Computing, specializing in the application of High Performance, Data Analytics and Cloud Computing to advance drug discovery. After 14 years in the role, he moved to the Markley Group as CTO and subsequently joined AWS in 2020 as Principal Business Development Lead for HPC in Healthcare and Life Science
Michael oversees the executive management of RCH, including the company’s overall strategic direction, and brings more than 25 years of experience to his role. His primary responsibilities are business development, sales, and marketing. Michael has been an officer since 2006 and was instrumental in the evolution of the company’s business model. RCH has experienced significant market and revenue growth in the Life Sciences and Healthcare industries during this time.